A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen
- PMID: 26855151
- DOI: 10.1038/bmt.2015.354
A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen
Similar articles
-
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.Biol Blood Marrow Transplant. 2005 Nov;11(11):903-11. doi: 10.1016/j.bbmt.2005.07.010. Biol Blood Marrow Transplant. 2005. PMID: 16275593 Clinical Trial.
-
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.Cancer Med. 2021 Apr;10(7):2250-2258. doi: 10.1002/cam4.3687. Epub 2021 Mar 5. Cancer Med. 2021. PMID: 33675184 Free PMC article. Clinical Trial.
-
Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.Clin Genitourin Cancer. 2015 Oct;13(5):453-60. doi: 10.1016/j.clgc.2015.05.003. Epub 2015 May 16. Clin Genitourin Cancer. 2015. PMID: 26072101 Free PMC article. Clinical Trial.
-
High dose chemotherapy in germ cell tumors.Tunis Med. 2005 Dec;83 Suppl 12:85-6. Tunis Med. 2005. PMID: 16430076 Review. No abstract available.
-
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.Curr Treat Options Oncol. 2012 Jun;13(2):201-11. doi: 10.1007/s11864-012-0199-z. Curr Treat Options Oncol. 2012. PMID: 22623055 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources